Quick Takeaways
- CNTX - Context Therapeutics Inc. has 15 insiders with reported activity on this page.
- Net insider value flow over the last year: +$107,086.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 15 Insiders of Context Therapeutics Inc.
- Symbol
- CNTX on Nasdaq
- Location
- Philadelphia, PA
What Changed
- Buy value: $107,086; sell value: $0.
- Net share flow: +160,010.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$107,086.
Buys
$107,086
Shares: 160,010
Insiders: 3
Sells
$0
Shares: 0
Insiders: 0
Net
+$107,086
Shares: +160,010
Insiders: 3
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 160,010 | 0 | $107,086 | $0 | +$107,086 |
Context Therapeutics Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Martin A. Lehr | Chief Executive Officer, Director | $769,435 | +$70,080 | +10% | Mixed | 19 Feb 2026 |
| Alex C. Levit | Chief Legal Officer, Corp. Sec | $58,030 | +$11,520 | +25% | Mixed | 19 Feb 2026 |
| Lynn Minai Azary | Chief Financial Officer | $50,966 | +$25,486 | +100% | Filing P/S | 19 Feb 2026 |
| Tarek Sahmoud | Chief Medical Officer | $8,415 | Mixed | 16 Aug 2022 | ||
| Andy Pasternak | Director | Mixed | 12 Jun 2025 | |||
| Jennifer Evans Stacey | Director | Mixed | 12 Jun 2025 | |||
| Philip W. Kantoff | Director | Mixed | 12 Jun 2025 | |||
| Linda West | Director | Mixed | 12 Jun 2025 | |||
| William F. Rencher | Former Section 16 officer | Mixed | 15 Feb 2022 | |||
| Evan G. Dick | Former Section 16 officer | Mixed | 15 Feb 2022 | |||
| Karen Deborah Chagin | Chief Medical Officer | Mixed | 19 Feb 2026 | |||
| Richard J. Berman | Director | Mixed | 13 Jun 2024 | |||
| Ullmann Claudio Dansky | Chief Medical Officer | Mixed | 13 Feb 2025 | |||
| Luke Nathaniel Walker | Director | Mixed | 12 Jun 2025 | |||
| Karen L. Smith | Director | Mixed | 12 Jun 2025 |
Top shareholders of Context Therapeutics Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MPM BioImpact LLC |
13F
13D/G
|
Company |
12%
from 13D/G
|
10,679,391
|
$27,980,004 | — | 31 Mar 2026 | |
| Avidity Partners Management LP |
13D/G
13F
|
Company |
8.7%
|
8,302,808
|
$21,753,357 | -$2,352,163 | 31 Mar 2026 | |
| Deep Track Capital, LP |
13F
13D/G
|
Company |
8.3%
from 13D/G
|
7,419,355
|
$19,438,710 | — | 31 Mar 2026 | |
| Nextech Invest, Ltd. |
13F
|
Company |
8.1%
|
7,419,355
|
$19,438,710 | — | 31 Mar 2026 | |
| Soleus Capital Master Fund, L.P. |
13D/G
|
— |
7.6%
|
6,963,141
|
$18,243,429 | +$5,729,267 | 31 Mar 2026 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
7.6%
|
6,963,141
|
$18,243,429 | — | 31 Mar 2026 | |
| Octagon Capital Advisors LP |
13D/G
13F
|
Company |
5.7%
|
5,250,000
|
$13,755,000 | $0 | 31 Mar 2026 | |
| Blue Owl Capital Holdings LP |
13D/G
13F
|
Company |
5.5%
|
5,089,015
|
$13,333,219 | -$3,324,552 | 31 Mar 2026 | |
| FRANKLIN RESOURCES INC |
13F
13D/G
|
Company |
4.5%
from 13D/G
|
3,803,338
|
$9,964,746 | — | 31 Mar 2026 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.7%
|
3,431,953
|
$8,991,717 | — | 31 Mar 2026 | |
| MARSHALL WACE, LLP |
13F
|
Company |
3.2%
|
2,948,441
|
$7,724,916 | — | 31 Mar 2026 | |
| TCG Crossover Management, LLC |
13F
|
Company |
2.9%
|
2,682,696
|
$7,028,664 | — | 31 Mar 2026 | |
| GREAT POINT PARTNERS LLC |
13F
13D/G
|
Company |
2.4%
from 13D/G
|
2,238,496
|
$5,864,860 | — | 31 Mar 2026 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.6%
|
1,424,374
|
$3,731,860 | — | 31 Mar 2026 | |
| Squadron Capital Management LLC |
13F
|
Company |
1.2%
|
1,100,000
|
$2,882,000 | — | 31 Mar 2026 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.2%
|
1,093,894
|
$2,866,002 | — | 31 Mar 2026 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.1%
|
1,000,000
|
$2,620,000 | — | 31 Mar 2026 | |
| Sio Capital Management, LLC |
13F
|
Company |
1%
|
917,922
|
$2,404,956 | — | 31 Mar 2026 | |
| BlackRock, Inc. |
13F
|
Company |
0.92%
|
846,696
|
$2,218,344 | — | 31 Mar 2026 | |
| Martin A. Lehr |
13D/G
3/4/5
|
Martin Lehr · Chief Executive Officer, Director |
2.1%
|
1,595,742
|
$1,595,742 | $0 | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.66%
|
603,767
|
$1,582,701 | — | 31 Mar 2026 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.58%
|
529,550
|
$1,387,421 | — | 31 Mar 2026 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.48%
|
436,931
|
$1,144,760 | — | 31 Mar 2026 | |
| VANGUARD FIDUCIARY TRUST CO |
13F
|
Company |
0.37%
|
341,344
|
$894,321 | — | 31 Mar 2026 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.31%
|
287,299
|
$752,723 | — | 31 Mar 2026 | |
| Woodline Partners LP |
13F
|
Company |
0.27%
|
250,088
|
$655,231 | — | 31 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
0.25%
|
233,507
|
$611,788 | — | 31 Mar 2026 | |
| Seven Fleet Capital Management LP |
13F
|
Company |
0.21%
|
190,785
|
$499,857 | — | 31 Mar 2026 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.2%
|
182,999
|
$479,457 | — | 31 Mar 2026 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.15%
|
140,017
|
$366,845 | — | 31 Mar 2026 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.14%
|
126,152
|
$330,518 | — | 31 Mar 2026 | |
| Pathstone Holdings, LLC |
13F
|
Company |
0.12%
|
110,244
|
$288,839 | — | 31 Mar 2026 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.11%
|
104,973
|
$275,000 | — | 31 Mar 2026 | |
| Mill Creek Capital Advisors, LLC |
13F
|
Company |
0.11%
|
104,631
|
$274,133 | — | 31 Mar 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
103,256
|
$270,531 | — | 31 Mar 2026 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.11%
|
100,000
|
$262,000 | — | 31 Mar 2026 | |
| Clear Harbor Asset Management, LLC |
13F
|
Company |
0.1%
|
92,804
|
$243,146 | — | 31 Mar 2026 | |
| WINTON GROUP Ltd |
13F
|
Company |
0.09%
|
81,303
|
$213,014 | — | 31 Mar 2026 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.09%
|
80,600
|
$211,172 | — | 31 Mar 2026 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.06%
|
57,231
|
$149,945 | — | 31 Mar 2026 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.06%
|
50,912
|
$133,389 | — | 31 Mar 2026 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.03%
|
26,534
|
$69,519 | — | 31 Mar 2026 | |
| Virtu Financial LLC |
13F
|
Company |
0.03%
|
23,100
|
$61,000 | — | 31 Mar 2026 | |
| Alex C. Levit |
3/4/5
|
Chief Legal Officer, Corp. Sec |
—
mixed-class rows
|
351,983
mixed-class rows
|
$58,030 | +$11,520 | 19 Feb 2026 | |
| Cerity Partners LLC |
13F
|
Company |
0.02%
|
20,000
|
$52,400 | — | 31 Mar 2026 | |
| Lynn Minai Azary |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
355,010
mixed-class rows
|
$50,966 | +$25,486 | 19 Feb 2026 | |
| Sanctuary Advisors, LLC |
13F
|
Company |
0.02%
|
19,316
|
$50,608 | — | 31 Mar 2026 | |
| Vanguard Global Advisers, LLC |
13F
|
Company |
0.01%
|
12,612
|
$33,043 | — | 31 Mar 2026 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.01%
|
12,573
|
$32,941 | — | 31 Mar 2026 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
12,182
|
$31,917 | — | 31 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for Context Therapeutics Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Alex C. Levit | CNTX | Stock Option (right to buy) | Award | 270,000 | 270,000 | 19 Feb 2026 | Direct | |||
| Lynn Minai Azary | CNTX | Stock Option (right to buy) | Award | 275,000 | 275,000 | 19 Feb 2026 | Direct | |||
| Karen Deborah Chagin | CNTX | Stock Option (right to buy) | Award | 290,000 | 290,000 | 19 Feb 2026 | Direct | |||
| Martin A. Lehr | CNTX | Stock Option (right to buy) | Award | 815,000 | 815,000 | 19 Feb 2026 | Direct | |||
| Andy Pasternak | CNTX | Stock Option (right to buy) | Award | 138,900 | 138,900 | 12 Jun 2025 | Direct | |||
| Philip W. Kantoff | CNTX | Stock Option (right to buy) | Award | 123,500 | 123,500 | 12 Jun 2025 | Direct | |||
| Karen L. Smith | CNTX | Stock Option (right to buy) | Award | 123,500 | 123,500 | 12 Jun 2025 | Direct | |||
| Jennifer Evans Stacey | CNTX | Stock Option (right to buy) | Award | 123,500 | 123,500 | 12 Jun 2025 | Direct | |||
| Luke Nathaniel Walker | CNTX | Stock Option (right to buy) | Award | 123,500 | 123,500 | 12 Jun 2025 | Direct | |||
| Linda West | CNTX | Stock Option (right to buy) | Award | 123,500 | 123,500 | 12 Jun 2025 | Direct | |||
| Martin A. Lehr | CNTX | Common Stock | Purchase | 12.2% | $70,080 | $0.7008 | 100,000 | 920,190 | 09 Jun 2025 | Martin Lehr 2000 Trust |
| Karen Deborah Chagin | CNTX | Stock Option (right to buy) | Award | 153,000 | 153,000 | 09 Jun 2025 | Direct | |||
| Alex C. Levit | CNTX | Common Stock | Purchase | 222.2% | $11,520 | $0.5760 | 20,000 | 29,000 | 06 Jun 2025 | Direct |
| Lynn Minai Azary | CNTX | Common Stock | Purchase | 100% | $25,486 | $0.6370 | 40,010 | 80,010 | 06 Jun 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.